Tempus AI, Inc. (NASDAQ:TEM – Get Free Report) shares gapped down prior to trading on Monday . The stock had previously closed at $73.77, but opened at $69.78. Tempus AI shares last traded at $67.50, with a volume of 328,322 shares trading hands.
Wall Street Analysts Forecast Growth
Several research analysts have weighed in on the stock. Piper Sandler restated a “neutral” rating and set a $70.00 target price (up from $40.00) on shares of Tempus AI in a research report on Tuesday. JPMorgan Chase & Co. upped their price objective on shares of Tempus AI from $42.00 to $47.00 and gave the company an “overweight” rating in a research note on Wednesday, August 7th. Stifel Nicolaus cut Tempus AI from a “buy” rating to a “hold” rating and lifted their price target for the company from $45.00 to $65.00 in a report on Monday. Needham & Company LLC restated a “buy” rating and set a $47.00 price objective on shares of Tempus AI in a report on Wednesday, August 7th. Finally, Bank of America lowered shares of Tempus AI from a “buy” rating to a “neutral” rating and raised their price target for the company from $45.00 to $60.00 in a report on Wednesday, October 2nd. Three research analysts have rated the stock with a hold rating and seven have issued a buy rating to the company’s stock. Based on data from MarketBeat, the stock currently has an average rating of “Moderate Buy” and an average price target of $54.22.
Read Our Latest Stock Analysis on TEM
Tempus AI Stock Performance
Institutional Trading of Tempus AI
Several institutional investors and hedge funds have recently bought and sold shares of the company. Dakota Wealth Management acquired a new position in Tempus AI during the 3rd quarter valued at about $1,185,000. Davidson Kempner Capital Management LP bought a new stake in shares of Tempus AI during the 2nd quarter worth $2,271,000. NEA Management Company LLC acquired a new stake in Tempus AI during the 2nd quarter worth about $160,048,000. Exchange Traded Concepts LLC purchased a new stake in shares of Tempus AI in the 3rd quarter valued at approximately $3,458,000. Finally, Sculptor Capital LP purchased a new position in shares of Tempus AI during the second quarter valued at $5,085,000.
About Tempus AI
Tempus AI Inc is a technology company advancing precision medicine through the practical application of artificial intelligence principally in healthcare. The company provides AI-enabled precision medicine solutions to physicians to deliver personalized patient care and in parallel facilitates discovery, development and delivery of optimal therapeutics.
Featured Articles
- Five stocks we like better than Tempus AI
- High Dividend REITs: Are They an Ideal Way to Diversify?
- 3 Solar Stocks at Bargain Prices: Big Opportunities Ahead
- There Are Different Types of Stock To Invest In
- Is Bitcoin’s Trump Card a Boom or Bust?
- Upcoming IPO Stock Lockup Period, Explained
- Cloudflare Is a Solid Buy for 2025
Receive News & Ratings for Tempus AI Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Tempus AI and related companies with MarketBeat.com's FREE daily email newsletter.